CROSSWICKS, N.J.--(BUSINESS WIRE)--The Myelodysplastic Syndromes (MDS) Foundation announced today that data presented at this year’s American Society of Clinical Oncology (ASCO) meeting in Chicago demonstrate significant advances in the treatment of patients with MDS which are helping patients to live longer with a better quality of life.
